The evolution of commercial drug delivery technologies

AM Vargason, AC Anselmo, S Mitragotri - Nature biomedical …, 2021 - nature.com
Drug delivery technologies have enabled the development of many pharmaceutical
products that improve patient health by enhancing the delivery of a therapeutic to its target …

Cancer-associated adipocytes: key players in breast cancer progression

Q Wu, B Li, Z Li, J Li, S Sun, S Sun - Journal of hematology & oncology, 2019 - Springer
Adipocytes are one of the primary stromal cells in many tissues, and they are considered to
play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) …

The landscape of targeted therapies in TNBC

E Vagia, D Mahalingam, M Cristofanilli - Cancers, 2020 - mdpi.com
Triple negative breast cancer (TNBC) constitutes the most aggressive molecular subtype
among breast tumors. Despite progress on the underlying tumor biology, clinical outcomes …

Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors

TK Rimkus, RL Carpenter, S Qasem, M Chan, HW Lo - Cancers, 2016 - mdpi.com
The sonic hedgehog (Shh) signaling pathway is a major regulator of cell differentiation, cell
proliferation, and tissue polarity. Aberrant activation of the Shh pathway has been shown in …

New angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis

I Larionova, E Kazakova, T Gerashchenko… - Cancers, 2021 - mdpi.com
Simple Summary Since the targeting of a single pro-angiogenic factor fails to improve
oncological disease outcome, significant efforts have been made to identify new pro …

Secondary arterial hypertension: when, who, and how to screen?

SF Rimoldi, U Scherrer, FH Messerli - European heart journal, 2014 - academic.oup.com
Secondary hypertension refers to arterial hypertension due to an identifiable cause and
affects∼ 5–10% of the general hypertensive population. Because secondary forms are rare …

Recent advances in nanostrategies capable of overcoming biological barriers for tumor management

D Huo, X Jiang, Y Hu - Advanced Materials, 2020 - Wiley Online Library
Engineered nanomaterials have been extensively employed as therapeutics for tumor
management. Meanwhile, the complex tumor niche along with multiple barriers at the …

[HTML][HTML] Targeting the tumor vasculature to enhance T cell activity

E Lanitis, M Irving, G Coukos - Current opinion in immunology, 2015 - Elsevier
Highlights•Tumor vessels form a physical barrier that hampers intratumoral T cell
trafficking.•Tumor endothelial cells can directly kill T cells or suppress their …

Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: potencial clinical application

C Merino-González, FA Zuñiga, C Escudero… - Frontiers in …, 2016 - frontiersin.org
Mesenchymal stem cells (MSCs) are adult multipotent stem cells that are able to differentiate
into multiple specialized cell types including osteocytes, adipocytes, and chondrocytes …

Immunoliposomes: A review on functionalization strategies and targets for drug delivery

JO Eloy, R Petrilli, LNF Trevizan, M Chorilli - Colloids and Surfaces B …, 2017 - Elsevier
Nanoparticles, especially liposomes, have gained prominence in the field of drug delivery
for the treatment of human diseases, particularly cancer; they provide several advantages …